CXCL13 and cancer: Next, we use TIGER to analyze the CD4-CXCL13-T cell distribution throughout the cancer versus paracancer, and the results showed that tumor tissue contained a proportion of 86.96% of CD4-CXCL13-T cells (Figure 10G, 10H).